These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8737135

  • 1. Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group.
    Jaillon P, Morganroth J, Brumpt I, Talbot G.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():161-7. PubMed ID: 8737135
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QTc interval).
    Morganroth J, Talbot GH, Dorr MB, Johnson RD, Geary W, Magner D.
    Clin Ther; 1999 May; 21(5):818-28. PubMed ID: 10397377
    [Abstract] [Full Text] [Related]

  • 5. Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers.
    Demolis JL, Charransol A, Funck-Brentano C, Jaillon P.
    Br J Clin Pharmacol; 1996 Jun; 41(6):499-503. PubMed ID: 8799513
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacin.
    Morganroth J, Hunt T, Dorr MB, Magner D, Talbot GH.
    Clin Ther; 1999 Sep; 21(9):1514-24. PubMed ID: 10509846
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group.
    Ortqvist A, Valtonen M, Cars O, Wahl M, Saikku P, Jean C.
    Chest; 1996 Dec; 110(6):1499-506. PubMed ID: 8989068
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.
    Aubier M, Verster R, Regamey C, Geslin P, Vercken JB.
    Clin Infect Dis; 1998 Jun; 26(6):1312-20. PubMed ID: 9636854
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA, Miller B, Schwartz R, Henry DC, Nolan T, McCabe A, Magner DJ, Talbot GH.
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men.
    Phillips I, Dimian C, Barlow D, Moi H, Stolz E, Weidner W, Perea E.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():123-34. PubMed ID: 8737132
    [Abstract] [Full Text] [Related]

  • 19. Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men.
    Moi H, Morel P, Gianotti B, Barlow D, Phillips I, Jean C.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():115-22. PubMed ID: 8737131
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.